Rolziracetam
From Wikipedia, the free encyclopedia
 |
|
|---|---|
 |
|
| Systematic (IUPAC) name | |
| dihydro-1H-pyrrolizine-3,5(2H,6H)-dione | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Unscheduled (US) |
| Routes | Oral |
| Identifiers | |
| CAS number | 18356-28-0  |
| ATC code | None |
| PubChem | CID 71893 |
| ChemSpider | 64906  |
| UNII | RES9I0LGG5 |
| ChEMBL | CHEMBL51396 |
| Synonyms | 2,6,7,8-tetrahydro-1H-pyrrolizine-3,5-dione |
| Chemical data | |
| Formula | C7H9N2O2 |
| Mol. mass | 139.152 g/mol |
| SMILES | eMolecules & PubChem |
|
|
 (what is this?) (verify) |
|
Rolziracetam is a nootropic drug of the racetam family.
Rolziracetam was found to improve performance on a delayed-response task in aged rhesus monkeys. It has a wide margin of safety in animals and has been evaluated for use in cognitively impaired human subjects. [1]
[edit] See also
[edit] References
- ^ Butler DE, Leonard JD, Caprathe BW, L'Italien YJ, Pavia MR, Hershenson FM, Poschel PH, Marriott JG. Amnesia-reversal activity of a series of cyclic imides. Journal of Medicinal Chemistry. 1987 Mar;30(3):498-503.
|
|||||
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
